You are here

Article info

Article menu
Download PDFPDF
Colon
Original article
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer

Authors

  • Yoshinaga Okugawa Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Yuji Toiyama Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan PubMed articlesGoogle scholar articles
  • Shusuke Toden Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Hiroki Mitoma Baylor Institute for Immunology Research, Baylor Research Institute, Baylor Health Care System, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Takeshi Nagasaka Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan PubMed articlesGoogle scholar articles
  • Koji Tanaka Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan PubMed articlesGoogle scholar articles
  • Yasuhiro Inoue Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan PubMed articlesGoogle scholar articles
  • Masato Kusunoki Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan PubMed articlesGoogle scholar articles
  • C Richard Boland Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Ajay Goel Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ajay Goel, Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute, Baylor University Medical Center, 3500 Gaston Ave, Suite H-250, Dallas, TX 75246, USA; ajay.goel{at}baylorhealth.edu
View Full Text

Citation

Okugawa Y, Toiyama Y, Toden S, et al
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
Gut 2017;66:107-117.

Publication history

  • Received February 10, 2015
  • Revised August 21, 2015
  • Accepted September 5, 2015
  • First published October 15, 2015.
Online issue publication 
June 29, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/